POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (8.5.2021, 6:08pm CEST, WHO):   U.S. 114,820    India 42,982    Brazil 32,316    Russia 23,120    France 28,769    The United Kingdom 28,936    Turkey 26,822    Argentina 14,850    Columbia 6,929    Spain 21,876    Italy 6,590    Iran 39,357    Germany 3,539    Indonesia 35,764    Mexico 18,911    South Africa 13,263    Ukraine 1,052    Peru 2,207    The Netherlands 2,836    Iraq 12,713    Philippines 7,342    Bangladesh 12,744    Malaysia 19,819    Pakistan 4,722    Portugal 3,203    Japan 14,053    Nepal 3,007    Thailand 20,920    United Arab Emirates 1,519    Morocco 10,603    Tunisia 3,163    Lebanon 1,532    Saudi Arabia 1,043    Greece 2,855    Georgia 3,670    Cuba 9,363    Guatemala 4,399    Myanmar 4,132    Ireland 1,217    Honduras 1,128    Libya 2,485    Kenya 1,335    South Korea 1,776    Vietnam 7,295    Algeria 1,495    Mongolia 1,178    Mozambique 1,034    Fiji 1,187    Eswatini 1,068    China 108    Singapore 95    New Zealand 1    Australia 256   

Kenya urges Africa to reinforce surveillance on malaria drug resistance

Staff Writer |
Kenya called on Sub Saharan African (SSA) to step up surveillance on malaria drug resistance in the region.

Article continues below




Ben Andagalu, principal investigator of malaria at Kenya Medical Research Institute (KEMRI) said that the countries should offer oversight on quality of malaria drugs coming into the countries.

"The procurement of malaria drugs needs to be procured by a centralized agency to help save populations from accessing outdated medicine," Andagalu told the annual scientific and health conference in Nairobi.

Andagalu told health experts that artemisinin-based combination therapies (ACT) malaria drugs that were recommended by the World Health Organization (WHO) as the first line of treatment for plasmodium falciparum malaria has started showing resistance in South East Asian countries of Myanmar, Vietnam, Cambodia and Thailand.

"Africa is currently spared but historically, malaria drug resistance has originated from South East Asia and then spread to Africa," the researcher noted.

He said that the resistance of Sulfadoxine pyrimethamine (SP), sold under the brand name Fansidar, started in South East Asia and spread to SSA save for Madagascar that still uses the drug without resistance.

Andagalu observed that the emergence of drug resistance to ACTs in SSA and especially Kenya will be disastrous, given there are limited alternative treatment options.

He called on governments to make quality of malaria healthcare high by ensuring that drugs entering the country are of utmost quality.

"Counterfeit drugs, substandard drugs and unregulated boundaries are to blame for drug resistance," he noted.

Andagalu cautioned against the sale of malaria drugs over the counter saying that the governments need to network patient diagnosis with the pharmacies where they purchase the drugs.

He said that the system that is being practiced by many countries ensures that patient data are logged in once a patient goes into pharmacy outlet.

"The system will enhance that patients gets quality drugs as prescribed as opposed to purchasing them over the pharmacy counter," he added.


What to read next

New drug effective against malaria
Genes that protect African children from malaria identified
3.2 billion people at risk of malaria